Huangdi Anxiao Attenuated High Glucose-Induced PC12 Cells Neurotoxicity via Inhibiting Apoptosis Pathway of Endoplasmic Reticulum Stress

Background: Huangdi Anxiao (HDAX) is mainly used to treat diabetes and its complications for many years and has a remarkable curative effect. However, the improvement effect of HDAX in the diabetic cognitive dysfunction (DCD) model and the related mechanism is not clear. This study was aimed to explore the neuroprotective effects of HDAX and its possible mechanisms in DCD. Methods A DCD cell model was established by high glucose-induced PC12 cells, and the effect of HDAX on the cell viability was examined by MTT. Additionally, the expression of relevant genes and proteins in the apoptosis pathway of endoplasmic reticulum (ER) stress was detected. Results The results showed that HDAX increased cell viability, reduced GRP78, CHOP, Bax, procaspase-12, procaspase-9, procaspase-3 mRNA levels and GRP78, CHOP, Bax, Caspase-12, Caspase-9, Caspase-3 protein expressions, and decreased Bcl-2 mRNA level and protein expression. Conclusions These results suggested that HDAX had neuroprotective effects in the DCD cell model, which may be associated with the inhibition of the apoptosis pathway of ER stress.